menu
    • menu

    Company profile for Agenus

    NEW Drugs in Dev: 21
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations. In addition to our broad portfolio, we have an accomplished team of scientists, novel technology platforms and end-to-end capabilities from new t...
    Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations. In addition to our broad portfolio, we have an accomplished team of scientists, novel technology platforms and end-to-end capabilities from new target discovery to GMP manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AgenusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3 Forbes Road Lexington, MA 02421-7305
    Telephone
    Telephone
    781.674.4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://agenusbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/agenus
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/agenus?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Agenus to Show First Phase 2 Botensilimab Melanoma Data
    Agenus to Show First Phase 2 Botensilimab Melanoma Data

    21 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260421965944/en/Agenus-to-Present-First-Phase-2-Botensilimab-Data-in-Advanced-Cutaneous-Melanoma-at-ASCO-2026

    BUSINESSWIRE
    21 Apr 2026
    Share Share
    Agenus Phase II Data Show Durable Survival in GEJ Cancer
    Agenus Phase II Data Show Durable Survival in GEJ Cancer

    17 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260417821181/en/Agenus-Reports-Phase-II-Data-Demonstrating-Immune-Reprogramming-and-Durable-Survival-with-Botensilimab-Balstilimab-and-agenT-797-in-PD-1-Refractory-Gastroesophageal-Cancer

    BUSINESSWIRE
    17 Apr 2026
    Share Share
    Agenus Highlight BOT+BAL Combo Data in PD-1 Refractory GEC Cancer
    Agenus Highlight BOT+BAL Combo Data in PD-1 Refractory GEC Cancer

    03 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260403035898/en/Agenus-Announces-Data-from-Phase-II-Study-of-BOTBAL-in-Combination-with-agent-797-in-PD-1-Refractory-Gastroesophageal-Cancer-to-be-Presented-at-AACR-2026

    BUSINESSWIRE
    03 Apr 2026
    Share Share
    Agenus Enrolls First Patient in Phase 3 BATTMAN mCRC Trial
    Agenus Enrolls First Patient in Phase 3 BATTMAN mCRC Trial

    01 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260401039214/en/Agenus-Announces-First-Patient-Enrolled-in-Global-Phase-3-BATTMAN-Trial-of-BOTBAL-Immunotherapy-Combination-in-MSS-or-pMMR-Metastatic-Colorectal-Cancer

    BUSINESSWIRE
    01 Apr 2026
    Share Share
    Agenus To Host Mar 2026 Webcast On BOT + BAL Strategy
    Agenus To Host Mar 2026 Webcast On BOT + BAL Strategy

    26 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260326480611/en/Agenus-to-Host-March-2026-Stakeholder-Webcast-Harnessing-the-Immune-System-to-Advance-BOT-BAL-Across-Tumor-Types-and-Expand-Patient-Access

    BUSINESSWIRE
    26 Mar 2026
    Share Share
    Agenus Unveils Botensilimab-Balstilimab at AACR
    Agenus Unveils Botensilimab-Balstilimab at AACR

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260317452517/en/Agenus-Announces-Upcoming-AACR-2026-Presentation-Evaluating-Botensilimab-Plus-Balstilimab-in-First-Line-MSS-Metastatic-Colorectal-Cancer

    BUSSINESSWIRE
    17 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search